Philip Hemme, Author at Labiotech.eu

About

Young French-German Entrepreneur, Co-founder & CEO of Labiotech.eu. High-level table tennis player, and German beer/French Wine lover 🙂

Articles by Philip Hemme

Inside Labiotech 23 May 2019

See you Labiotech, it has been an awesome ride 🚀

It’s with a lot of emotion that I’m announcing this news today. I will step down as CEO of Labiotech, while my co-founder Joachim will lead the company forward. At the end of June, I will step down, and then remain a shareholder and on the board of the company to keep supporting the team […]

May 23, 2019 - 4 minutesmins - By Philip Hemme

Inside Labiotech 14 Feb 2019

Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥

You might have noticed that something changed on our site today. Indeed, we’re very proud to launch our brand-new website, which we started from scratch on a blank piece of paper. We are further improving your user experience and the page performance, and we’ll have the possibility of adding more crazy features in the coming […]

February 14, 2019 - 4 minutesmins - By Philip Hemme

Inside Labiotech 12 Feb 2019

Why We Love Being the Main Media Partner of BIO-Europe

We love partnering with cool people and companies—in return, we get to be in the middle of the action, get our name out there, and bring you all the very best of the events we attend. One of our favorite partnerships is with EBD Group, which are running BIO-Europe. Here’s why we love partnering with […]

February 12, 2019 - 2 minutesmins - By Philip Hemme

Inside Labiotech 7 Nov 2018

What’s The Impact Of Labiotech On The Biotech Ecosystem? (Hint: It’s High … )

Our mission is to deliver the best content and to bring together people making up the biotech ecosystem in Europe. How do we do it? Is it actually impactful? If so, how? Let me try to answer… To start off, let’s take some perspective, what’s the current state of the connectivity of the biotech industry […]

November 7, 2018 - 3 minutesmins - By Philip Hemme

Best in Biotech 2 Jul 2018

13 Biotech Leaders You Should Know in the UK’s Golden Triangle

After listing the top biotech leaders in Munich, we investigated the ‘golden triangle’ in the UK to find out who are the most influential biotech leaders there. The so-called ‘golden triangle’ of universities in Oxford, Cambridge and London concentrates a large percentage of the UK’s biotech research and industry, ranging from big pharma, like AstraZeneca and GSK, […]

July 2, 2018 - 8 minutesmins - By Philip Hemme

Inside Labiotech 21 Dec 2017

How Labiotech is Surfing on the Digital Media Revolution

Media was the first industry to be disrupted by the digital revolution, aka “The Internet”. Most of the established media platforms are still trying to figure out what to do, especially on the revenues/profits side of things. On the other hand, some of the biggest players today were founded in the last 15 years, think […]

December 21, 2017 - 6 minutesmins - By Philip Hemme

Inside Labiotech 28 Sep 2017

Why does Labiotech.eu exist? (Not only to play table football together)

Our mission, since we started Labiotech.eu, has been to empower biotech ecosystems to better cure, feed and fuel the world. In our team, we all believe biotech is an industry that has an enormous impact on making the world a better place (I can’t actually think of any more impactful industry). Bill Gates recently told […]

September 28, 2017 - 3 minutesmins - By Philip Hemme

Inside Labiotech 21 Sep 2017

How we raised our second financing round? (Yes, it was tough)

You might have seen our press release or read about it on other media outlets, such as Tech.eu, EU-Startups, Gruenderszene.de, VC-Magazin, Deutsche-startups.de or Wan-Ifra: we just raised our second financing round. It’s a major milestone for the development of Labiotech.eu as it will allow us to continue investing in amazing content, launch new products and […]

September 21, 2017 - 6 minutesmins - By Philip Hemme

Inside Labiotech 18 Sep 2017

Press Release: We raised our second financing round to become the largest biotech media 🚀

Happy news to announce this morning: we just closed our second fundraising from new and existing investors 😉👌 It’s a major milestone for the development of Labiotech.eu as it will allow us to continue investing in amazing content, launch new products and grow our revenues. Thanks to the team for their amazing work and for making […]

September 18, 2017 - 3 minutesmins - By Philip Hemme

Expert Advice 15 Jun 2017

6 Ways to get Traction as a Biotech Startup

In 1989, Joshua Boger, founder of Vertex Pharmaceuticals, was on a mission to launch a new generation of biotech companies, but he didn’t have much to show. Fortunately, he understood rapidly that a biotech company needs a solid story in order to succeed. In biotech, “your story is your product”: people need to be enthusiastic […]

June 15, 2017 - 6 minutesmins - By Philip Hemme

Interview 8 May 2017

Meet the co-developer of the first commercial mAb and gene therapy

Sander van Deventer is now a managing partner at Forbion after playing a critical role in the development of the first commercial monoclonal antibody, Remicade, and the first market-approved gene therapy, Glybera. I was curious to know what he did to achieve such an impressive track record. Sander van Deventer was trained as an internist […]

May 8, 2017 - 5 minutesmins - By Philip Hemme

Inside Labiotech 27 Apr 2017

Wait but why is Labiotech.eu based in Berlin?

After “How do you make money,” that’s the question I am asked most. Here’s the answer for all the curious people out there! As you might already know, Labiotech.eu started in France. I was studying bioengineering with Joachim (the first guy I talked to on the first day of the first year!) at Sup’Biotech, and […]

April 27, 2017 - 4 minutesmins - By Philip Hemme

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Philip Hemme

About

Articles by Philip Hemme

See you Labiotech, it has been an awesome ride 🚀

Say Hello to The Brand-New Labiotech.eu, Our Biggest Product Redesign Since We Launched 💥

Why We Love Being the Main Media Partner of BIO-Europe

What’s The Impact Of Labiotech On The Biotech Ecosystem? (Hint: It’s High … )

13 Biotech Leaders You Should Know in the UK’s Golden Triangle

How Labiotech is Surfing on the Digital Media Revolution

Why does Labiotech.eu exist? (Not only to play table football together)

How we raised our second financing round? (Yes, it was tough)

Press Release: We raised our second financing round to become the largest biotech media 🚀

6 Ways to get Traction as a Biotech Startup

Meet the co-developer of the first commercial mAb and gene therapy

Wait but why is Labiotech.eu based in Berlin?

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

About

Articles by Philip Hemme

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!